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To the Editor,
The efficacy of allergen immunotherapy depends on the quality of allergen extracts. 
Currently, biological methods based on intradermal skin tests or skin prick tests are utilized 
for the preparation and standardization of reference allergen extracts.1 A competitive 
inhibition assay is normally used for in vitro comparison of allergenic potency and 
standardization of new preparations.2 However, quantification of major allergen content is 
needed for better allergen standardization. The concentration of major allergen in an extract 
is proportional to its allergenic activity, and maintenance doses (5 to 20 μg/dose, 50 to 250 
μg/yr) of the major allergen are necessary for effective subcutaneous immunotherapy.3 The 
Japanese Society of Allergology determined allergenic potency based on Der p 1 and Der f 1 
content, concluding that 38.5 μg/mL of Der 1 is equivalent to 100,000 JAU/mL.4
A monoclonal antibody (mAb)-based sandwich enzyme-linked immunosorbent assay (ELISA) 
for the quantification of Der f 1 and Der p 1 was first developed in 19895 and is currently in 
wide use. More recently, tandem mass spectrometry has begun to be utilized for allergen 
quantification.6 However, its use is limited due to the need for expensive instruments and 
highly trained staffs for routine use.
The study presented here was undertaken to develop a new sensitive, two-site ELISA for 
quantification of Der f 1. Hybridomas producing mAbs were prepared by immunization with 
recombinant (r) Der f 1, which was produced in Pichia as previously described.7 First, 17 clones that 
strongly recognized rDer f 1 were selected by ELISA. Five clones (1C9, 1G8, 3D7, 13C5, and 13F7) 
that showed good reactivity both in ELISA and western blotting were selected for further cloning 
(Figure A and B). However, western blotting showed that clones 1C9 and 13F7 did not retain the 
ability to recognize Der f 1. The combination of 3D7 as a capture antibody and biotinylated 13F7 
as a detection antibody showed optimal results for the detection of Der f 1 in the extract. The 
detection limits were as low as 50 ng/mL of extract and 2 pg/mL of rDer f 1 (Figure C and D).
Der f 1 content in the 4 commercial extracts was 3.47–19.16 μg/mL when using the Indoor 
Biotechnologies antibodies and 2.79–18.59 μg/mL with the investigatory antibodies 
(Supplementary Fig. S1). No significant difference was shown between the results obtained 
by the 2 kits (P = 0.1 to 0.7). Der f 1 concentrations in the 21 dust samples were 18–363.2 ng/g 
dust with Indoor Biotechnologies antibodies and 14–322.5 ng/g dust with the investigatory 
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antibodies (Figure E). The Pearson's correlation coefficient between the 2 assays was 
0.876824 (P < 0.0001). As expected, Der f 1 content in the commercial extracts and dust 
samples was not significantly different between the two-site ELISA systems.
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Figure. Specificity of monoclonal antibodies to Der f 1. Analysis by 15% sodium dodecyl sulfate polyacrylamide gel electrophoresis of allergen extracts from three 
species of dust mite: Dermatophagoides pteronyssinus (Dp), D. farinae (Df), and Tyrophagus putrescentiae (Tp) (A). Detection of native Der f 1 by monoclonal 
antibodies 3D7 (B). Detection of native Der f 1 in allergen extract by a two-site ELISA system. The two-site ELISA was quantified with doubling dilutions of the 
extract from 390 ng/mL of the extract (C). The two-site ELISA was quantified with doubling dilutions from 20 pg/mL of recombinant Der f 1 (D). Arrows indicate 
the detection limits. Comparison of Der f 1 concentration in house dust samples quantified by two ELISA systems (E). 
mAb, monoclonal antibody; ELISA, enzyme-linked immunosorbent assay.
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In conclusion, we developed novel mAbs against rDer f 1 useful for both qualitative and quantitative 
analyses. The antibodies should also be useful for the assessment of allergen exposure.
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Supplementary Fig. S1
Comparison of Der f 1 content in commercial Dermatophagoides farinae extracts quantified by 
two enzyme-linked immunosorbent assay systems.
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